SCHEMBL26309809

SCHEMBL26309809

CC(C)(Cn1c2ccccc2c2ccccc21)Cn1c2ccccc2c2ccccc21

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.56
CYP2C19 P33261 1/20 0.56
CYP19A1 P11511 1/20 0.48
BACE1 P56817 2/20 0.47
PER2 O15055 6/20 0.46
GPR3 P46089 1/20 0.46
KDM4E B2RXH2 2/20 0.45
ALDH1A1 P00352 2/20 0.45
MEN1 O00255 1/20 0.43
MAPT P10636 1/20 0.43
HPGD P15428 1/20 0.43
MAPK1 P28482 1/20 0.43
HTT P42858 1/20 0.43
HBB P68871 1/20 0.43
KMT2A Q03164 1/20 0.43
HSD17B10 Q99714 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
FABP3 P05413 1/20 0.42
FABP4 P15090 1/20 0.42
FABP5 Q01469 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12386908 0.90 CYP1A2 (0.50) CYP1A2CYP2C19CYP19A1BACE1PER2
SCHEMBL18539423 0.88 CYP1A2 (0.48) CYP1A2CYP2C19CYP19A1BACE1PER2
SCHEMBL13111957 0.86 CYP1A2 (0.56) CYP1A2CYP2C19CYP19A1BACE1PER2
SCHEMBL1128885 0.83 CYP1A2 (0.52) CYP1A2CYP2C19CYP19A1BACE1PER2
SCHEMBL23148499 0.77 CYP1A2 (0.56) CYP1A2CYP2C19CYP19A1BACE1PER2
SCHEMBL18715068 0.75 PER2 (0.49) CYP1A2CYP2C19PER2KDM4EALDH1A1
SCHEMBL18546098 0.75 ALDH1A1 (0.44) CYP1A2CYP2C19CYP19A1BACE1PER2
SCHEMBL19590449 0.75 PER2 (0.49) CYP1A2CYP2C19PER2KDM4EALDH1A1
SCHEMBL18539424 0.75 KDM4E (0.39) CYP1A2CYP2C19PER2KDM4EALDH1A1
SCHEMBL29963695 0.73 ALDH1A1 (0.75) CYP1A2CYP2C19CYP19A1BACE1GPR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230292591-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2023-09-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230292591-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES POF1B, FOSB, OSBP CYP1A2 2035/4885CYP2C19 2105/4885CYP19A1 1572/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.